tiprankstipranks
Trending News
More News >
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market
Advertisement

Nautilus Biotechnolgy (NAUT) Financial Statements

Compare
145 Followers

Nautilus Biotechnolgy Financial Overview

Nautilus Biotechnolgy's market cap is currently $104.68M. The company's EPS TTM is $-0.12; its P/E ratio is ―; Nautilus Biotechnolgy is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Nautilus Biotechnolgy Earnings and Revenue History

Nautilus Biotechnolgy Debt to Assets

Nautilus Biotechnolgy Cash Flow

Nautilus Biotechnolgy Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis